000 | 01526cam a2200397 a 4500 | ||
---|---|---|---|
001 | 90013134 | ||
003 | DLC | ||
005 | 20230131131350.0 | ||
008 | 901029s1991 enka b 001 0 eng c | ||
010 | _a90013134 | ||
020 | _a9780471928904 | ||
020 | _a0471928909 | ||
040 |
_aDNLM/DLC _cDLC _dDLC _dUtOrBLW |
||
050 | 0 | 0 |
_aRM332 _b.F45 1991 |
060 | _aQV 126 F297s | ||
082 | 0 | 0 |
_a616.85/27061 _220 |
082 | 0 |
_bPLC _a616.8918 |
|
082 | 0 |
_bSLH _a616.8918 |
|
100 | 1 |
_aFeighner, John Preston, _d1937- |
|
245 | 1 | 0 |
_aSelective serotonin re-uptake inhibitors : _bthe clinical use of citalopram, fluoxetine, fluvoxamine, paroxetine, and sertraline / _cJ.P. Feighner and W.F. Boyer. |
260 |
_aChichester ; _aNew York : _bWiley, _cc1991. |
||
300 |
_a168 p. : _bill. (some col.) ; _c24 cm. |
||
490 | 1 |
_aPerspectives in psychiatry ; _vv. 1 |
|
504 | _aIncludes bibliographical references and index. | ||
650 | 0 | _aAntidepressants. | |
650 | 0 | _aSerotonin uptake inhibitors. | |
650 | 0 | _aSerotoninergic mechanisms. | |
650 | 2 |
_aDepression _xdrug therapy. |
|
650 | 2 |
_aDepressive Disorders _xdrug therapy. |
|
650 | 2 |
_aSerotonin Antagonists _xtherapeutic use. |
|
650 | 2 |
_aMental Disorders _xdrug therapy |
|
700 | 1 | _aBoyer, W. F. | |
830 | 0 |
_aPerspectives in psychiatry (Chichester, England) ; _vv. 1. |
|
856 | 4 | 2 |
_3Publisher description _uhttp://www.loc.gov/catdir/enhancements/fy0607/90013134-d.html |
856 | 4 | 1 |
_3Table of contents _uhttp://www.loc.gov/catdir/enhancements/fy0607/90013134-t.html |
999 |
_c52397 _d52397 |
||
883 |
_h32175 _gThomas Veale |